Ensysce Biosciences Earnings Estimate

ENSC Stock  USD 5.34  0.05  0.93%   
The next projected EPS of Ensysce Biosciences is estimated to be -3.1125 with future projections ranging from a low of -3.1125 to a high of -3.1125. Ensysce Biosciences' most recent 12-month trailing earnings per share (EPS TTM) is at -31.5. Please be aware that the consensus of earnings estimates for Ensysce Biosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Ensysce Biosciences is projected to generate -3.1125 in earnings per share on the 31st of December 2024. Ensysce Biosciences earnings estimates show analyst consensus about projected Ensysce Biosciences EPS (Earning Per Share). It derives the highest and the lowest estimates based on Ensysce Biosciences' historical volatility. Many public companies, such as Ensysce Biosciences, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Ensysce Biosciences' earnings estimates, investors can diagnose different trends across Ensysce Biosciences' analyst sentiment over time as well as compare current estimates against different timeframes. As of February 27, 2025, Gross Profit is expected to decline to about (5.1 M). In addition to that, Pretax Profit Margin is expected to decline to -5.75
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ensysce Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.

Ensysce Biosciences Earnings Estimation Breakdown

The calculation of Ensysce Biosciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Ensysce Biosciences is estimated to be -3.1125 with the future projection ranging from a low of -3.1125 to a high of -3.1125. Please be aware that this consensus of annual earnings estimates for Ensysce Biosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.07
-3.11
Lowest
Expected EPS
-3.1125
-3.11
Highest

Ensysce Biosciences Earnings Projection Consensus

Suppose the current estimates of Ensysce Biosciences' value are higher than the current market price of the Ensysce Biosciences stock. In this case, investors may conclude that Ensysce Biosciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Ensysce Biosciences' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2024Current EPS (TTM)
021.2%
0.07
-3.1125
-31.5

Ensysce Biosciences Earnings per Share Projection vs Actual

Actual Earning per Share of Ensysce Biosciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Ensysce Biosciences predict the company's earnings will be in the future. The higher the earnings per share of Ensysce Biosciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.
JavaScript chart by amCharts 3.21.15MarSepSepMar-30-25-20-15-10-505
JavaScript chart by amCharts 3.21.15Highest Estimate Lowest Estimate Estimated EPS Actual EPS

Ensysce Biosciences Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Ensysce Biosciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Ensysce Biosciences should always be considered in relation to other companies to make a more educated investment decision.
JavaScript chart by amCharts 3.21.15MarSepSepMar-30-25-20-15-10-505
JavaScript chart by amCharts 3.21.15Actual Estimated

Ensysce Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Ensysce Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-07
2024-09-30-0.290.070.36124 
2024-08-08
2024-06-30-0.39-0.220.1743 
2024-05-13
2024-03-31-0.9-0.550.3538 
2024-03-15
2023-12-31-0.87-1.37-0.557 
2023-11-09
2023-09-30-1.06-0.870.1917 
2023-08-11
2023-06-30-2.73-0.981.7564 
2023-05-15
2023-03-31-5.08-2.083.059 
2023-03-30
2022-12-31-28.88-18.2410.6436 
2022-11-14
2022-09-30-3.2-0.742.4676 
2022-08-11
2022-06-30-3.4-4.8-1.441 
2022-05-12
2022-03-31-3.2-1.22.062 
2022-03-31
2021-12-31-0.4-9.0-8.62150 
2021-11-15
2021-09-30-0.71-0.710.0

About Ensysce Biosciences Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Ensysce Biosciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Ensysce Biosciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Ensysce Biosciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-109.4 M-103.9 M
Retained Earnings Total Equity-1.1 M-1 M
Earnings Yield(0.34)(0.36)
Price Earnings Ratio(3.05)(3.21)
Price Earnings To Growth Ratio 0.03  0.03 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ensysce Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ensysce Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ensysce Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ensysce Biosciences Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ensysce Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensysce Biosciences. If investors know Ensysce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensysce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(31.50)
Revenue Per Share
10.216
Quarterly Revenue Growth
6.853
Return On Assets
(0.63)
Return On Equity
(2.05)
The market value of Ensysce Biosciences is measured differently than its book value, which is the value of Ensysce that is recorded on the company's balance sheet. Investors also form their own opinion of Ensysce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ensysce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensysce Biosciences' market value can be influenced by many factors that don't directly affect Ensysce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensysce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensysce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensysce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.